<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药笔记 | wechat-feeds</title><link>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</link><description>乘之愈往，识之愈真。如将不尽，与古为新。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 19 Feb 2021 11:59:56 +0800</pubDate><image><url>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</url><title>医药笔记 | wechat-feeds</title><link>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>多特异性纳米抗体：或成对抗新冠变异的有效武器</title><link>https://mp.weixin.qq.com/s/Osl0PQ2_cGfYcMg1XOJxAw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBcB95sutrj87VnKHEgO5ZJofLKUyyuBnjY8D1dNzWKAk624EicnhLy3ibA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>纳米双抗狙击新冠]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>成立6个月，联拓生物启动FGFR抑制剂三期临床</title><link>https://mp.weixin.qq.com/s/Q2ne2z7Bi8gdtWjs7v74Sg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBccP7w31xoDCBWrQA0tqK025J6gKwMOA2sOS2opYN3EyMsribn0APwk9Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>FGFR]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>国内首个：迈威生物申报ST2抗体</title><link>https://mp.weixin.qq.com/s/fddboQe5XXcv0p4qwCDRqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBsxX389pNL7NRWFFkSzpZuSEqgpoMuTKcK5AOLTYpe90icYIS7DB5Ac2CiaQ6c2ImT2Ww1mjkmRJIA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>IL-33/ST2]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>David Baker成功实现跨膜TMB的从头设计</title><link>https://mp.weixin.qq.com/s/i3saMA1qCCfPA2u-SswR9A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBsxX389pNL7NRWFFkSzpZuyDTTSL8VJgedbE5YOPAhEUcgyHm9R3p0qHGMiawdI2aONKd0axp4gCw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>蛋白从头设计]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>全人源抗体</title><link>https://mp.weixin.qq.com/s/DXGT00Exm8PNDsfg39pcrg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBcTibmic8ZBd30Gq7icel0fnVD79kggnZ3whxLzgOafoyje0DoI4eL83xXw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>710亿美元]]></content:encoded><pubDate>Thu, 18 Feb 2021 09:08:33 +0800</pubDate></item><item><title>豪森药业1.32亿美元引进抗真菌感染药物</title><link>https://mp.weixin.qq.com/s/NHZQyII9835qPZY6HoDQNA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBcv6RHw8FM4OicBLiaxUicgpFynoKwXRAdibMbcoNALEaGibiaAlotXhibXbicAA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>预付款1000万美元]]></content:encoded><pubDate>Thu, 18 Feb 2021 09:08:33 +0800</pubDate></item><item><title>百济神州1.21亿美元引进TNFR2抗体</title><link>https://mp.weixin.qq.com/s/qSPj13mwcXnuO6qIiAcmLw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBciaYyBMCGxf1HAQI9N3spMAl5ZZeQ3X2BXAahcUSr9JZrW9VtDEPORxw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>TNFR2]]></content:encoded><pubDate>Thu, 18 Feb 2021 09:08:33 +0800</pubDate></item><item><title>WHO批准阿斯利康新冠疫苗</title><link>https://mp.weixin.qq.com/s/gTlk4ikOP40W8uAOoPjm1w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNB9sFUJkdrrf9UFN8Px1LCph7UPH9Z1R1jBz3H1vlJfblUoQkrkwtTe1gpZQgacznN1JldcqNeR0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>WHO第二款]]></content:encoded><pubDate>Wed, 17 Feb 2021 00:35:14 +0800</pubDate></item><item><title>Bluebird基因疗法患者出现1例血液瘤副作用，股价暴跌30%</title><link>https://mp.weixin.qq.com/s/h_68nxO5zWojvIbE2TJnCg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNB9sFUJkdrrf9UFN8Px1LCp392YQia7ybVd2mL1zrxBKAvibD7d46rqIWaruZuibG1lRa0DIUXvTzUIA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>满病毒载体]]></content:encoded><pubDate>Wed, 17 Feb 2021 00:35:14 +0800</pubDate></item><item><title>O药、K药大战一线肾癌</title><link>https://mp.weixin.qq.com/s/rL5byhCPNyWzKtiyvTs1zw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBGp976lVnLRGbJ4ZrydFS7ib9eysV6ticeHtbibYo6hk9s1f3BGibJVzHqm3tCwANnbBS6yDPAFx8bew/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>拉上小分子帮手]]></content:encoded><pubDate>Sun, 14 Feb 2021 11:59:15 +0800</pubDate></item><item><title>FDA批准第100款抗体药</title><link>https://mp.weixin.qq.com/s/WI7Kk-3pbMKyoVi1967-oQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBicCShYMfVicX9fcZOQd0bHEGho2qNsyCo8VsBTZBrUib8HUKMSyO1h9QJUFibQmJe0ZicsiaDAL2Xu54A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>100]]></content:encoded><pubDate>Sat, 13 Feb 2021 10:07:33 +0800</pubDate></item><item><title>K药头对头：翰思生物PD-1启动非小细胞肺癌2/3期临床</title><link>https://mp.weixin.qq.com/s/WhX4qcDvH00JDRh84jiNVw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCbvUdYrxSCMvxEgNwt7uYlrnzsdEnACUtsd4Dtoc76oJmywYlKhoiarJ1wIrbiblIy1e6CZhD6czUA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>K药头对头]]></content:encoded><pubDate>Thu, 11 Feb 2021 23:40:46 +0800</pubDate></item><item><title>创响生物IL-17类抗体申报临床</title><link>https://mp.weixin.qq.com/s/USwtIP2fVGteIfz2mbHbLQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCbvUdYrxSCMvxEgNwt7uYlYPeZnvolhDIwUyDcDJjbNmw0d9bd0MpVzRLcLQPfZ2YAnO4zU7CaZQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Affibody]]></content:encoded><pubDate>Thu, 11 Feb 2021 23:40:46 +0800</pubDate></item><item><title>CRISPR：艾伯维3.4亿美元获Caribou技术授权，开发通用CAR-T疗法</title><link>https://mp.weixin.qq.com/s/JaQjqtwbEzdMYgNaITs3cw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVND2AnCmm8icpEmjVkAUmMn6vdv23R7hn51GdmzTfoiaAAD1II9ZKzKdToiczevDadqM0Vv8Sqhnwxpnw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T+CRISPR]]></content:encoded><pubDate>Thu, 11 Feb 2021 10:55:01 +0800</pubDate></item><item><title>ADC：Genmab/Seagen向FDA递交Tisotumab Vedotin的上市申请</title><link>https://mp.weixin.qq.com/s/XUyyKl772jc7cB_WfehAFA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCbvUdYrxSCMvxEgNwt7uYlm8lu7PAxtQIib8TZibtPWco2ePLem5tmzsicBhDIqiaoib7DW7G9IuKZhibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>靶向TF]]></content:encoded><pubDate>Thu, 11 Feb 2021 10:55:01 +0800</pubDate></item><item><title>新型HER2 ADC：华人科学家研发，对HER2低表达有效</title><link>https://mp.weixin.qq.com/s/TwHUB98zSRYmJWOyu7rWwg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCbvUdYrxSCMvxEgNwt7uYlGtaCNHvHG475Wr5ZuXhgKCVibVb0okaJzesVOR0TwgPl2icbVzqdx2Dg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>鹅膏毒素]]></content:encoded><pubDate>Thu, 11 Feb 2021 10:55:01 +0800</pubDate></item><item><title>George Church发明新型AAV载体，降低免疫原性</title><link>https://mp.weixin.qq.com/s/GADhQAcQ2dPDEbW72g0IWA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCbvUdYrxSCMvxEgNwt7uYlpmqRSpqsWaVhCLsMvRnL68sNoia16GebicAFvG0tlYaprjib2rClrAXEw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新型AAV载体，插入TLR9拮抗的短序列]]></content:encoded><pubDate>Thu, 11 Feb 2021 10:55:01 +0800</pubDate></item><item><title>李氏大药厂PD-L1抗体即将申报上市：</title><link>https://mp.weixin.qq.com/s/0LvVZYZqkIZ0ZcgT8WcE4Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDJeQuA2KZ4gHbQoNhhm9NQhNDsjJic5j2K8B3z6h8ON2LhiaRzVLCzTHGFv95atckcNCzHhfclEZJQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>▎Armstrong2021年2月9日，李氏大药厂宣布PD-L1抗体Socazolimab（ZKAB001）]]></content:encoded><pubDate>Wed, 10 Feb 2021 05:37:57 +0800</pubDate></item><item><title>天演药业纳斯达克上市，当天股价大涨58%</title><link>https://mp.weixin.qq.com/s/7AHY4CkET5Of5wrR1rpu1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDJeQuA2KZ4gHbQoNhhm9NQeOdaJ51INeG1GUUBvO92lukzQDHtN8AqtauNBqia3XERpaIoVukQa0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>市值12.65亿美元]]></content:encoded><pubDate>Wed, 10 Feb 2021 05:37:57 +0800</pubDate></item><item><title>TCR疗法先驱：Immunocore上市两天市值翻倍，药明等投资</title><link>https://mp.weixin.qq.com/s/YSr3ZZbq_HeJSwUQ7jj6Fg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDJeQuA2KZ4gHbQoNhhm9NQafUMqVYC3LEPaZiaSkEUeI93ja7IeeI2IhXaDK5vlialaAKseaVeRfnQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>immTAC]]></content:encoded><pubDate>Wed, 10 Feb 2021 05:37:57 +0800</pubDate></item></channel></rss>